Trending

Japan

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Eisai has launched its insomnia drug Dayvigo in Japan, the second in a new class of medicines after

X

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

https://pharmaphorum.com/news/chasing-merck-eisai-launches-insomnia-drug-dayvigo-in-japan/

The Japanese healthcare revolution

The Japanese healthcare revolution

Something that always strikes me when visiting Japan is the uber-modern infrastructure and services enjoyed by residents and

X

The Japanese healthcare revolution

https://pharmaphorum.com/views-analysis-oncology/the-japanese-healthcare-revolution/

Trial sets up 2020 filing for Poxel’s novel diabetes drug

Trial sets up 2020 filing for Poxel’s novel diabetes drug

French biotech Poxel has positive phase 3 data for a new type of oral therapy for type 2

X

Trial sets up 2020 filing for Poxel’s novel diabetes drug

https://pharmaphorum.com/news/trial-sets-up-2020-filing-for-poxels-novel-diabetes-drug/

Promethera looks to Asia with €10m investment

Promethera looks to Asia with €10m investment

Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of

X

Promethera looks to Asia with €10m investment

https://pharmaphorum.com/news/promethera-looks-to-asia-with-e10m-investment/

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment

X

AstraZeneca gets further approval for Tagrisso in Japan

https://pharmaphorum.com/news/astrazeneca-tagrisso-approval/

AstraZeneca cancer drugs approved in Japan

AstraZeneca cancer drugs approved in Japan

AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months

X

AstraZeneca cancer drugs approved in Japan

https://pharmaphorum.com/r-d/astrazenecas-cancer-drugs-approved-japan/

AZ tried to buy Daiichi Sankyo last year – report

AZ tried to buy Daiichi Sankyo last year – report

Trading in shares of Daiichi Sankyo was suspended yesterday.

X

AZ tried to buy Daiichi Sankyo last year – report

https://pharmaphorum.com/news/az-tried-buy-daiichi-sankyo-last-year-report/

Regulatory timelines in the Asia-Pacific

Regulatory timelines in the Asia-Pacific

Snapshot of clinical trial application processes in the region.

X

Regulatory timelines in the Asia-Pacific

https://pharmaphorum.com/views-and-analysis/regulatory-timelines-asia-pacific/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com